Clemens M. Doppler

Chairman at 4SC AG

67 year

Commercial Services

Health Technology

Finance

Profile

Clemens M.
Doppler is currently Chairman-Supervisory Board at 4SC AG since 2014, Chairman at MerLion Pharmaceuticals Pte Ltd. since 2006, Chairman-Supervisory Board at MerLion Pharmaceuticals GmbH, Chairman at 3i Private Equity, Managing Director at Heidelbergcapital General Partner GmbH since 2008, Managing Partner at HeidelbergCapital Asset Management GmbH since 2008, Member at DVFA e.V., and Member-Supervisory Board at Verinos Pharmaceuticals GmbH.
Former positions include Chairman at Accovion GmbH from 2008 to 2015, Vice Chairman-Supervisory Board at Sensovation AG from 2009 to 2013, Business Development Director & Head-department at Phoenix International Life Sciences, Inc. from 1994 to 2000, Director-Business Development & Head-department at Phoenix International Life Sciences, Inc. (Switzerland) from 1994 to 2000, Director at Merlion Trade GmbH, Investment Manager at 3i Group Plc from 2000 to 2007, Investment Manager at Technologie Holding, Member-Supervisory Board at vasopharm GmbH, and Member-Supervisory Board at Nanogate SE.
Education includes graduate and doctorate degrees from Ruprecht-Karls-Universität Heidelberg.

Clemens M. Doppler active positions

Companies	Position	Start
4SC AG	Chairman	2014-09-18
MerLion Pharmaceuticals GmbH MerLion Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development of natural sciences, engineering, agricultural sciences and medicine	Chairman	-
Heidelbergcapital General Partner GmbH	Chief Executive Officer	2007-12-31
MerLion Pharmaceuticals Pte Ltd. MerLion Pharmaceuticals Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibiotics	Chairman	2005-12-31
DVFA e.V.	Corporate Officer/Principal	-
HeidelbergCapital Asset Management GmbH HeidelbergCapital Asset Management GmbH Investment ManagersFinance HCAM is a private equity investment manager specializing in secondary direct investments. They acquire portfolios of minority shareholdings from private equity and venture capital firms as well as investment banks. Their targeted range of investments includes early-stage companies which are already past the startup-phase and have a proven business model, as well as established medium-sized family-owned businesses and small-cap listed companies. They may consider investing in a single company on a case-by-case basis. They are active partners for their portfolio companies, and get involved in strategic decisions. Their strategy includes investing growth capital in the companies in which they have acquired a stake.	Private Equity Investor	2007-12-31
3i Private Equity 3i Private Equity Investment ManagersFinance 3i Private Equity invests in middle market companies located in Europe and North America with an enterprise value of EUR 100 - 500 million. The firm targets companies operating in the fields of consumer & private label, healthcare, industrial, services and software sectors. It provides financing for buyout and growth stage capital requirements also acquires majority and minority interest and also makes co-investments.	Private Equity Investor	-

All active positions of Clemens M. Doppler

Former positions of Clemens M. Doppler

Companies	Position	End
Merlion Trade GmbH	Director/Board Member	2021-01-22
Accovion GmbH Accovion GmbH Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development services	Chairman	2014-12-31
░░░░░░░░░░░ ░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░ ░░░░░ ░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░

See the detail of Clemens M. Doppler's experience

Training of Clemens M. Doppler

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Clemens M. Doppler's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	17
Phoenix International Life Sciences, Inc. Phoenix International Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides bioanalytical research and clinical testing services	Commercial Services
3i Group Plc 3i Group Plc Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust	Miscellaneous
4SC AG 4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment	Health Technology
Technologie Holding Technologie Holding Financial ConglomeratesFinance Provides Internet investment services	Finance
Accovion GmbH Accovion GmbH Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development services	Commercial Services
vasopharm GmbH vasopharm GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases	Health Technology
Ruprecht-Karls-Universität Heidelberg Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sensovation AG Sensovation AG Electronic Equipment/InstrumentsElectronic Technology Manufactures and markets scientific imaging instrumentation technologies	Electronic Technology
MerLion Pharmaceuticals Pte Ltd. MerLion Pharmaceuticals Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibiotics	Health Technology
Nanogate SE Nanogate SE Industrial MachineryProducer Manufacturing Designs, develops and produces composite and surface treatments	Producer Manufacturing
3i Private Equity 3i Private Equity Investment ManagersFinance 3i Private Equity invests in middle market companies located in Europe and North America with an enterprise value of EUR 100 - 500 million. The firm targets companies operating in the fields of consumer & private label, healthcare, industrial, services and software sectors. It provides financing for buyout and growth stage capital requirements also acquires majority and minority interest and also makes co-investments.	Finance
HeidelbergCapital Asset Management GmbH HeidelbergCapital Asset Management GmbH Investment ManagersFinance HCAM is a private equity investment manager specializing in secondary direct investments. They acquire portfolios of minority shareholdings from private equity and venture capital firms as well as investment banks. Their targeted range of investments includes early-stage companies which are already past the startup-phase and have a proven business model, as well as established medium-sized family-owned businesses and small-cap listed companies. They may consider investing in a single company on a case-by-case basis. They are active partners for their portfolio companies, and get involved in strategic decisions. Their strategy includes investing growth capital in the companies in which they have acquired a stake.	Finance
Merlion Trade GmbH
DVFA e.V.
MerLion Pharmaceuticals GmbH MerLion Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development of natural sciences, engineering, agricultural sciences and medicine	Commercial Services
Heidelbergcapital General Partner GmbH
Phoenix International Life Sciences,Inc. (Switzerland)